Catalyst Pharmaceuticals, Inc. (CPRX) Financials

CPRX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 1.1 billion 134.9 million
Dec. 31, 2025 1.1 billion 152.5 million
Sept. 30, 2025 1.1 billion 131.4 million
June 30, 2025 971.9 million 115.9 million

CPRX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 59.6 million 6.3 million
Dec. 31, 2025 44.9 million 5.7 million
Sept. 30, 2025 32.4 million 5.7 million
June 30, 2025 71.3 million 7.6 million

CPRX Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 63.7 million
Dec. 31, 2025 52.7 million
Sept. 30, 2025 52.8 million
June 30, 2025 52.1 million

CPRX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 755.9 million - 2.2 million
Dec. 31, 2025 709.2 million - 2.4 million
Sept. 30, 2025 689.9 million - 2.9 million
June 30, 2025 652.8 million - 3.0 million

CPRX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 126.9 million
Dec. 31, 2025 127.3 million
Sept. 30, 2025 127.1 million
June 30, 2025 127.5 million

CPRX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 27000 2.7 million 49.3 million -
Dec. 31, 2025 32000 1.8 million 53.4 million 33.6 million
Sept. 30, 2025 - 2.7 million 47.5 million 2.9 million
June 30, 2025 26000 4.4 million 45.9 million 3.7 million

CPRX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 149.4 million 24.2 million
Dec. 31, 2025 152.6 million 26.1 million
Sept. 30, 2025 148.4 million 25.3 million
June 30, 2025 146.6 million 30.0 million

CPRX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

CPRX

Price: $31.37

52 week price:
19.05
32.56

Earnings Per Share: 1.73 USD

P/E Ratio: 18.04

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.7 million

Ebitda: -4.3 million

Market Capitalization: 3.8 billion

Links: